Changhua County Commissioner Wang Hui-mei’s (王惠美) victory in last month’s nine-in-one elections brought a change in local governance that has raised concern over possible increased political risk for offshore wind farm investment, although wind power developers can still secure power purchase agreements with a more favorable feed-in tariff of NT$5.8498 per kilowatt-hour if they receive permits from the local government and the Bureau of Energy, and submit the documents to Taiwan Power Co (Taipower, 台電) by Wednesday.
Six offshore wind projects among four developers were on Dec. 21 approved by the Ministry of the Interior. The developers — Orsted A/S, Hai Long Offshore Wind (海龍), a joint venture by Northland Power Inc and Yushan Energy Co (玉山能源), Copenhagen Infrastructure Partners and China Steel Corp (中鋼) — still need to gain approval from the local government and the bureau to qualify for the higher tariff, but as of Friday — before the New Year’s Day long weekend — they had not received them.
“Approval from the local government is essential for the bureau to issue the permit,” Bureau of Energy section head Chen Chung-hsien (陳崇憲) told the Taipei Times by telephone on Friday.
Photo: CNA, provided by Changhua County Government
The bureau has thus far issued no permits for the six projects, because it received a letter from the Changhua County Government on Friday indicating that the local government has reservation about the projects, as well as doubts over the developers’ plans to cooperate with local fishers, Chen said.
As the Changhua County Government did not clearly say whether it agreed with the projects, but only expressed reservations, the bureau found it difficult to issue the permits, Chen said.
“Changhua’s agreement marks the final regulatory hurdle for developers,” he said.
If the county government under Wang, who was sworn in on Tuesday last week, approves the projects, the bureau would issue the permit and give other documents to the developers, which are necessary for them to secure agreements with Taipower, Chen said.
The Chinese Nationalist Party’s (KMT) Wang beat former Changhua county commissioner Wei Ming-ku (魏明谷) of the Democratic Progressive Party in Nov. 24’s vote.
The four developers are waiting to sign agreements with the state-run utility, Taipower spokesman Hsu Tsao-hua (徐造華) said.
Given that the final working day of this year, today, is within the long weekend and tomorrow is a national holiday, the developers have until Wednesday to secure the lucrative rate, if they gain permits from the local government and the bureau, Hsu said, citing Civil Code regulations.
The bureau has a proposal to drop the rate to NT$5.106 per kilowatt hour, a cap that is to be in place for 20 years for projects approved after Wednesday.
However, the proposed 12.7 percent reduction in feed-in tariffs for offshore wind projects has met resistance from developers and companies in their supply chains, and the Ministry of Economic Affairs last week agreed to reassess the metrics used to decide the tariff after receiving feedback from industry representatives at public hearings.
Wang could not be reached for comment as of press time last night.
Changhua Department of Economic Affairs Director Liu Yu-ping (劉玉平) said that the county government could not agree to the projects for the time being, as the developers had only made vague promises to local fishers, local Chinese-language media reported.
Developers need to communicate more with local fishers, the reports quoted Liu as saying, adding that by adopting the new rate it would save tax revenue of as much as NT$120 billion (US$3.9 billion) over 20 years.
Apple Inc might make one out of four iPhones in India by 2025, JPMorgan & Chase Co analysts said yesterday, as the tech giant moves some production away from China, amid mounting geopolitical tensions and strict COVID-19 lockdowns in the country. JPMorgan expects Apple to move about 5 percent of iPhone 14 production from late this year to India, which is the second-biggest smartphone market in the world after China. It is also estimating that about 25 percent of all Apple products, including Mac, iPad, Apple Watch and AirPods, would be manufactured outside China by 2025 from 5 percent currently. The US company
HEADING SOUTH: The US company chose Kaohsiung as its site as more customers, partners and start-ups have expanded their operations to the southern city Qualcomm Inc yesterday inaugurated a new innovation center in Kaohsiung as it steps up efforts to foster local start-ups and a 5G technology ecosystem in the city, following in the footsteps of its local partners. The US chip company’s move fits the Kaohsiung City Government’s plan to build a semiconductor supply chain within the next five years, highlighted by Taiwan Semiconductor Manufacturing Co’s (TSMC, 台積電) first chip plant in the city. TSMC plans to start building the factory by the end of this year, and to start production of 28-nanometer and 7-nanometer chips there in 2024. Qualcomm said it had been
SLUMPING DEMAND: Inventory has climbed by up to 12 weeks as suppliers are under mounting pressure to offload excessive reserves, a TrendForce report said The price of DRAM chips is expected to fall at a steeper rate of 13 to 18 percent next quarter, as high inflation continues to weigh on demand for consumer electronics, causing chip inventories to soar, market researcher TrendForce Corp (集邦科技) said yesterday. The downtrend in DRAM prices could extend from a quarterly decline of 10 to 15 percent in the third quarter, the Taipei-based researcher said. “Demand for consumer electronics continued to stagnate during the third quarter, which used to be a high demand season,” TrendForce said in a statement. “During the quarter, memorychip consumption and shipments both showed quarterly
GlaxoSmithKline (GSK) in July made its consumer health products division a separate entity as it transforms into a world-leading biopharmaceutical company. By uniting science, technology and talent, the company is aiming to prevent and treat diseases with innovative vaccines, specialty pharmaceuticals and general medicines. GSK’s headquarters annually invests NT$192 billion (US$6.07 billion) in research and development, focusing on immune science and advanced technologies in human genetics. GSK’s drug and vaccine development focuses on infectious diseases, HIV, oncology and immunology. Investing in clinical trial research each year, GSK also brings drug development to Taiwan. It cooperates with 17 medical institutes and research